Metabolic syndrome: Development of D.D.Pletnev’s and G.F.Lang’s ideas
https://doi.org/10.18093/0869-0189-2022-32-2S-13-21
Abstract
Metabolic syndrome is a problem of our time due to its high prevalence (from 20 to 50% in the adult population).
The aim of the work was to outline the main stages in the study of the totality of hemodynamic and metabolic disorders that was later designated “metabolic syndrome”, in Russia. The article focuses on the development of the ideas of D.D.Pletnev and G.F.Lang from the beginning of the 20th century to the present at the Department of Faculty Therapy in Petrograd Medical Institute for Women, which was later named the First Leningrad Medical Institute and is now named Federal State Budgetary Educational Institution of Higher Education Academician I.P.Pavlov First St. Petersburg State Medical University under the Ministry of Healthcare of Russian Federation. The article discusses current trends in the study of the metabolic syndrome, including data from epidemiological studies on the prevalence of the metabolic syndrome and its individual components in Russia.
Results. The paper presents the results of molecular genetic and instrumental methods for examining patients with abdominal obesity, metabolic syndrome, including those with complications such as atrial fibrillation, coronary heart disease, chronic heart failure with preserved left ventricular fraction. The review presents data on the molecular and other features of subcutaneous and visceral (epicardial) adipose tissue.
Conclusion. The paper outlines priority areas for studying the metabolic syndrome in the future, which will be important for preventing the development and progression of this pathological condition.
About the Authors
Yu. Sh. Khalimov
Federal State Budgetary Educational Institution of Higher Education “Academician I.P.Pavlov First St. Petersburg State Medical University”, Ministry of Healthcare of Russian Federation
Russian Federation
Russian Federation
Yuriy Sh. Khalimov, Doctor of Medicine, Professor, Acting Head, Department of Faculty Therapy with a Course of Endocrinology, Cardiology with a Clinic; Chief Endocrinologist, Health Committee of the Government of St. Petersburg, Chief Endocrinologist, Ministry of Defense of the Russian Federation
tel.: (812) 338-66-46
E. I. Baranova
Federal State Budgetary Educational Institution of Higher Education “Academician I.P.Pavlov First St. Petersburg State Medical University”, Ministry of Healthcare of Russian Federation
Russian Federation
Russian Federation
Elena I. Baranova, Doctor of Medicine, Professor, Department of Therapy Faculty with a Course of Endocrinology, Cardiology with a Clinic
tel.: (812) 338-66-46
O. D. Belyaeva
Federal State Budgetary Educational Institution of Higher Education “Academician I.P.Pavlov First St. Petersburg State Medical University”, Ministry of Healthcare of Russian Federation
Russian Federation
Russian Federation
Olga D. Belyaeva, Doctor of Medicine, Associate, Professor, Department of
Therapy Faculty with a Course of Endocrinology, Cardiology with a Clinic
tel.: (812) 338-66-46
O. A. Berkovich
Federal State Budgetary Educational Institution of Higher Education “Academician I.P.Pavlov First St. Petersburg State Medical University”, Ministry of Healthcare of Russian Federation
Russian Federation
Russian Federation
Olga A. Berkovich, Doctor of Medicine, Professor, Professor of the Department of Therapy Faculty with a Course of Endocrinology, Cardiology with a Clinic
tel.: (812) 338-66-46
References
1. Simmons R.K., Alberti K.G.M.M., Gale E.A.M. et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO expert consultation. Diabetologia. 2010; 53 (4): 600–605. DOI: 10.1007/s00125-009-1620-4.
2. World Health Organization. European health for all database (HFA-DB). Available at: https://gateway.euro.who.int/en/datasets/european-health-for-all-database/ [Accessed: January 23, 2022].
3. Shlyakhto E.V., Konradi A.O., Rotar’ O.P., Solntsev V.N. [The impact of the choice of criteria in the prevalence of metabolic syndrome]. Arterial’naya gipertenziya. 2009; 15 (4): 409–412. Available at: https://htn.almazovcentre.ru/jour/article/view/1402/0 (in Russian).
4. Boytsov S.A., Drapkina O.M., Shlyakhto E.V. et al. [Epidemiology of cardiovas-cular diseases and their risk factors in regions of Russian Federation (ESSE-RF) study: Ten years later]. Kardiovaskulyarnaya terapiya i profilaktika. 2021; 20 (5): 3007. DOI: 10.15829/1728-8800-2021-3007 (in Russian).
5. Balanova Yu.A., Shal’nova S.A., Deev A.D. et al. [Obesity in Russian population – prevalence and association with the non-communicable diseases risk factors]. Rossiyskiy kardiologicheskiy zhurnal. 2018; (6): 123–130. DOI: 10.15829/1560-4071-2018-6-123-130 (in Russian).
6. Alberti K.G.M.M., Eckel H.R., Grundy S.M. et al. Harmonizing the metabolic syndrome: A joint interim statement of the International diabetes Federation task force on epidemiology and prevention; national heart, lung, and blood institute; American Heart Association; World Heart Federation; International Atherosclerosis Society, and International Association for the Study of Obesity. Circulation. 2009; 120 (16): 1640–1645. DOI: 10.1161/circulationaha.109.192644.
7. Pletnev D.D. [Clinic and physiological experiment and their relationship]. Klinicheskaya meditsina. 1932; 10 (9): 99–107 (in Russian).
8. Lang G.F. [About hypertension: Mistakes in diagnosis and therapy]. Arkhiv Gosudarstvennogo klinicheskogo instituta dlya usovershenstvovaniya vrachey. 1922; 1: 16–25 (in Russian).
9. Anichkov N.N. [On the pathological processes associated with the deposition in the organs of birefringent]. In: [Proceedings of the Society of Russian doctors in St. Petersburg]. St. Petersburg; 1913: 90 (in Russian).
10. Myasnikov A.L. [About the cholesterol theory of atherosclerosis]. Meditsinskiy zhurnal. 1927; (2): 91 (in Russian).
11. Lang G.F., ed. [Textbook of Internal Medicine]. Leningrad: Medgiz; 1938 (in Russian).
12. Almazov V.A., Blagosklonnaya Ya.V., Shlyakhto E.V., Krasil’nikova E.I. [Metabolic Cardiovascular Syndrome]. St. Petersburg: Izdatel’stvo SPbGMU; 1999 (in Russian).
13. Blagosklonnaya Ya.V., Kudryashova M.I., Zalevskaya A.G., Mamedov R.B. [Some features of the clinic and the state of the ACTH-cortisol system in patients with android and gynoid types of primary obesity]. Zdravookhranenie Turkmenistana. 1985; (10): 19–22 (in Russian).
14. Krasil’nikova E.I., Blagosklonnaya Ya.V., Baranova E.I., Shlyakhto E.V. [From Lang to Reaven: History of the First Department of Internal Medicine at Pavlov St. Petersburg State Medical University]. Arterial’naya gipertenziya. 2012; 18 (4): 358–365. DOI: 10.18705/1607-419X-2012-18-4-358-365 (in Russian).
15. Chazova I., Almazov V.A., Shlyakhto E. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin. Diabetes Obes. Metab. 2006; 8 (4): 456–465. DOI: 10.1111/j.1463-1326.2006.00606.x.
16. Rotar’ O.P., Libis R.A., Isaeva E.N. et al. [Metabolic syndrome prevalence in Russian cities]. Rossiyskiy kardiologicheskiy zhurnal. 2012; 17 (2): 55–62. Available at: https://cyberleninka.ru/article/n/rasprostranennost-metabolicheskogo-sindroma-v-raznyh-gorodah-rf/viewer (in Russian).
17. Belyaeva O.D., Berezina A.V., Bazhenova E.A. et al. [Prevalence and forms of the metabolic syndrome in patients with abdominal obesity – in population of St.Petersburg]. Arterial’naya gipertenziya. 2012; 18 (3): 235–243. DOI: 10.18705/1607-419X-2012-18-3-235-243 (in Russian).
18. Belyaeva O.D., Brovin D.L., Karonova T.L. et al. [The level of adipocyte protein-4 binding fatty acids (FABP4) in abdominal obesity and metabolic syndrome in humans]. Rossiyskiy fiziologicheskiy zhurnal imeni I.M.Sechenova. 2017; 103 (4): 460–468 (in Russian).
19. Belyaeva O.D., Bazhenova E.A., Berezina A.V. [Adiponectin levels, lipid profile and glucose metabolism in patients with abdominal obesity]. Arterial’naya gipertenziya. 2009; 15 (3): 309–313. DOI: 10.18705/1607-419X-2009-15-3-309-313 (in Russian).
20. Belyaeva O.D., Brovin D.L., Berezina A.V. et al. [Total and high-molecular weight adiponectin level in hypertensive women with abdominal obesity]. Arterial’naya gipertenziya. 2014; 20 (5): 442–449. Available at: https://cyberleninka.ru/article/n/uroven-obschego-i-vysokomolekulyarnogo-adiponek-tina-u-zhenschin-s-abdominalnym-ozhireniem-i-arterialnoy-gipertenziey/viewer (in Russian).
21. Brovin D.L., Dracheva K.V., Panteleeva A.A. et al. [Gene ADIPOQ variants rs2441766 and rs266729: associationwith concentration of adiponectin (total and high molecular weight adiponectin), abdominal obesity and metabolic syndrome in women]. Meditsinskaya genetika. 2019; 18 (1): 25–34. DOI: 10.25557/2073-7998.2019.01.25-34 (in Russian).
22. Belyaeva O.D., Bazhenova E.A., Berezina A.V. et al. [Leptin level, genotype distribution and occurrence of A19G alleles of leptin gene polymorphism in patients with abdominal obesity]. Arterial’naya gipertenziya. 2009; 15 (4): 440–444. Available at: https://cyberleninka.ru/article/n/uroven-leptina-raspredelenie-genotipov-i-vstrechaemost-alleley-a19g-polimorfizma-gena-leptina-u-patsientov-s-abdominalnym-ozhireniem/viewer (in Russian).
23. Belyaeva O.D., Bazhenova E.A., Berezina A.V. et al. [Adiponectin in patients with abdominal obesity – carriers of different genotypes of the adiponectin gene]. Vestnik Sankt-Peterburgskogo universiteta. 2009; (4): 36–48. Available at: https://cyberleninka.ru/article/n/uroven-adiponektina-u-patsientov-s-abdominalnym-ozhireniem-nositeley-razlichnyh-genotipov-gena-adiponektina/viewer (in Russian).
24. Belyaeva O.D., Bazhenova E.A., Berezina A.V. et al. [Leptin level and Q223R polymorphism of leptin receptor’s gene in patients with abdominal obesity]. Problemy zhenskogo zdorov’ya. 2010; 5 (2): 28–34. Available at: http://www.gzrf.ru/com_publish/file/journal229.pdf (in Russian).
25. Korel’skaya N.A., Berezina A.V., Bazhenova E.A. et al. [A gene associated with fat mass and obesity and its role in the formation of metabolic syndrome components]. Vestnik Rossiyskoy akademii estestvennykh nauk. 2014; 18 (2): 109–118. Available at: http://www.raenjournal.ru/sites/default/files/032.pdf (in Russian).
26. Belyaeva O.D., Chubenko E.A., Berezina A.V. et al. [Abdominal obesity: the role of adipocytokines and polymorphisms of their genes in the development of metabolic syndrome components]. In: Shlyakhto E.V., ed. [Translational Medicine: Collection of papers]. St. Petersburg; 2010: 165–191 (in Russian).
27. Berezina A.V., Belyaeva O.D., Berkovich O.A. et al. Prevalence, risk factors, and genetic traits in metabolically healthy and unhealthy obese individuals. Biomed Res. Int. 2015: ID 548734. DOI: 10.1155/2015/548734.
28. Berezina A.V., Belyaeva O.D., Berkovich O.A. et al. [Change of the level of adiponectin and metabolic indices in modification of life style of the patients suffering from abdominal obesity]. Uchenye zapiski Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta imeni akademika I.P.Pavlova. 2015; 22 (1): 60–64. DOI: 10.24884/1607-4181-2015-22-1-60-64 (in Russian).
29. Nikitina I.L., Karonova T.L., Grineva E.N. [Vitamin D deficiency and health]. Arterial’naya gipertenziya. 2010; 16 (3): 277–281. Available at: https://cyberleninka.ru/article/n/defitsit-vitamina-d-i-zdorovie/viewer (in Russian).
30. Karonova T.L., Mikheeva E.P., Krasil’nikova E.I. et al. [Vitamin D deficiency is a risk factor for obesity and type 2 diabetes mellitus in reproductive age women]. Arterial’naya gipertenziya. 2012; 18 (1): 25–31. DOI: 10.18705/1607-419X-2012-18-1-25-31 (in Russian).
31. Karonova T.L., Grineva E.N., Mikheeva E.P. et al. [The level of vitamin D and its relationship with the amount of fatty tissue and adipocytokine content in the women of reproductive age]. Problemy endokrinologii. 2012; 58 (6): 19–23. DOI: 10.14341/probl201258619-23 (in Russian).
32. Karonova T.L., Shmonina I.A., Andreeva A.T. et al. [Vitamin D deficiency: the cause or the result of obesity?]. Consilium Medicum. 2016; 18 (4): 49–52. Available at: https://consilium.orscience.ru/2075-1753/article/view/94456 (in Russian).
33. Grineva E.N., Karonova T., Micheeva E. et al. Vitamin D deficiency is a risk factor for obesity and diabetes type 2 in women at late reproductive age. Aging (Albany NY). 2013; 5 (7): 575–581. DOI: 10.18632/aging.100582.
34. Karonova T.L., Belyaeva O.D., Bystrova A.A. et al. [Lipids profile in vitamin D insufficient/deficient subjects with different genotypes of vitamin D receptor gene]. Arterial’naya gipertenziya. 2019; 25 (5): 557–567. DOI: 10.18705/1607-419X-2019-25-5-557-567 (in Russian).
35. Karonova T., Grineva E., Belyaeva O. et al. Relationship between vitamin D status and vitamin D receptor gene polymorphisms with markers of metabolic syndrome among adults. Front. Endocrinol. (Laussane). 2018; 9: 448. DOI: 10.3389/fendo.2018.00448.
36. Polyakova A.A., Gudkova A.Yu., Krutikov A.N. et al. [Hypertrophic cardiomyopathy in the older age group: the effect of cardiometabolic risk factors and RS2290149 and RS10838692 of the MADD gene]. Arterial’naya gipertenziya. 2018; 24 (1): 29–40. DOI: 10.18705/1607-419X-2018-24-1-29-40 (in Russian).
37. Bazhenova E.A., Karonova T.L., Nikolaychuk E.I. et al. [Disorders of left ventricular diastolic function and anthropometric parameters in patients with abdominal obesity]. Arterial’naya gipertenziya. 2018; 24 (1): 65–73. DOI: 10.18705/1607-419X-2018-24-1-65-73 (in Russian).
38. Polyakova E.A., Zarayskiy M.I., Belyaeva O.D. et al. [Serum miRNA-203 expression in patients with coronary artery disease and abdominal obesity]. Doktor.Ru. 2019; (10 (165)): 6–10. DOI: 10.31550/1727-2378-2019-165-10-6-10 (in Russian).
39. Polyakova E.A., Zaraiskii M.I., Mikhailov E.N. et al. Association of myocardial and serum miRNA expression patterns with the presence and extent of coronary artery disease: A cross-sectional study. Int. J. Cardiol. 2021; 322: 9–15. DOI: 10.1016/j.ijcard.2020.08.043.
40. Ionin V.A., Listopad O.V., Nifontov S.E. et al. [Galectin 3 in patients with metabolic syndrome and atrial fibrillation]. Arterial’naya gipertenziya. 2014; 20 (5): 462–469. Available at: https://cyberleninka.ru/article/n/galektin-3-u-patsientov-s-metabolicheskim-sindromom-i-fibrillyatsiey-predserdiy/viewer (in Russian).
41. Ionin V.A., Listopad O.V., Nifontov S.E. et al. [Role of galectin 3 and epicardial fat thickness in the development of atrial fibrillation in patients with metabolic syndrome]. Uchenye zapiski Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta imeni akademika I.P.Pavlova. 2015; 22 (1): 43–46. DOI: 10.24884/1607-4181-2015-22-1-43-46 (in Russian).
42. Ionin V.A., Soboleva A.V., Listopad O.V. et al. [Galectin 3 and aldosterone in patients with atrial fibrillation and metabolic syndrome]. Rossiyskiy kardiologicheskiy zhurnal. 2015; (4): 79–83. DOI: 10.15829/1560-4071-2015-4-79-83 (in Russian).
43. Ionin V.A., Barashkova E.I., Pavlova V.A. et al. [What is the role of profibrogenic and proinflammatory factors in developing atrial fibrillation associated with metabolic syndrome components?]. Rossiyskiy kardiologicheskiy zhurnal. 2021; 26 (11): 4752. DOI: 10.15829/1560-4071-2021-4752 (in Russian).
44. Zaslavskaya E.L., Ionin V.A., Listopad O.V. et al. [Efficiency of radiofrequency ablation of pulmonary vein ostium for patients with atrial fibrillation and metabolics]. Uchenye zapiski Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta imeni akademika I.P.Pavlova. 2016; 23 (2): 39–42. Available at: https://www.sci-notes.ru/jour/article/view/329/279 (in Russian).
45. Zaslavskaya E.L., Ionin V.A., Nifontov S.E. et al. [Are epicardial adipose tissue and transforming growth factor beta1 risk factors of atrial fibrillation in patients with metabolic syndrome?]. Arterial’naya gipertenziya. 2018; 24 (3): 281–292. DOI: 10.18705/1607-419X-2018-24-3-281-292 (in Russian).
46.
Review
For citations:
Khalimov Yu.Sh., Baranova E.I., Belyaeva O.D., Berkovich O.A. Metabolic syndrome: Development of D.D.Pletnev’s and G.F.Lang’s ideas. PULMONOLOGIYA. 2022;32(2 (Прил)):13-21. (In Russ.) https://doi.org/10.18093/0869-0189-2022-32-2S-13-21
Views:
655
Email this article 